Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA spanks KVK Tech over impurities in ADHD drug
The FDA has found issues with the testing practices of a U.
‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050
Alzheimer’s Research UK has launched a new global initiative to “revolutionise” the early detection of neurodegenerative diseases like Alzheimer’s.
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
Paris - February 24, 2020 – Sanofi plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), whi...
Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics
Feb 24, 2020 Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder.
Biocon confident of approval for Lantus copy after Malaysia plant inspected by FDA a third time
With a new target date fast approaching for its competitor to Lantus, Biocon’s insulin manufacturing plant in Malaysia has again been given a once over by the FDA.
‘Record high’ two million people at type II diabetes risk
New NHS figures have revealed that approximately two million people in England are at risk of developing Type II diabetes, the highest on record.
New CRISPR base-editing technology slows ALS progression in mice
With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral scleros...
A better diagnosis of rare diabetes to adapt treatment
Diabetes affects more than 400 million people worldwide and is a major public health problem.
Opdivo/Yervoy continues to impress in kidney cancer
Bristol-Myers Squibb has announced that its Opdivo (nivolumab) and Yervoy (ipilimumab) combo has demonstrated superior overall survival, complete response rates and objective response ...
Teva’s Austedo flunks in late-stage paediatric Tourette study
Teva has announced that Austedo (deutetrabenazine) failed to meet its primary endpoints of reduction in motor and phonic tics in moderate-to-severe paediatric Tourette syndrome.
Audentes Therapeutics Announces Plans to Build New State-of-the-Art Gene Therapy Manufacturing Facility in Sanford, North Carolina
SAN FRANCISCO, CA and RALEIGH, N.
Merck Divests Allergopharma to Dermapharm Holding SE
Darmstadt, Germany - Merck, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE (“Dermapharm”).
369
370
371
372
373
374
375
376
377
